Neilaarshi Healthcare LLC is categorized under Wholesale Pharmaceutical Products in New York City, NY and active since 2013.
Neilaarshi Healthcare LLC was established in 2013, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Wholesale Pharmaceutical Products business, which does work in the B2B market, and is classified as a Wholesale Pharmaceutical Products, under code number 424210 by the NAICS.
If you are seeking more information, feel free to contact Krunal Vasani at the company’s single location by writing to 3750 Broadway, New York City, New York NY 10032 or by phoning (212) 368-5511. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Neilaarshi Healthcare LLC |
| Contact Person: | Krunal Vasani |
| Address: | 3750 Broadway, New York City, New York 10032 |
| Phone Number: | (212) 368-5511 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2013 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Wholesale Pharmaceutical Products |
| SIC Code: | 5122 |
| NAICS Code: | 424210 |
| Share This Business: |
Neilaarshi Healthcare LLC was started in 2013 to provide professional Wholesale Pharmaceutical Products under the SIC code 5122 and NAICS code 424210. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Krunal Vasani for inquiries that concern Neilaarshi Healthcare LLC by calling the company number (212) 368-5511, as your correspondence is most welcome. Additionally, the physical location of the single location of Neilaarshi Healthcare LLC can be found at the coordinates as well as the street address 3750 Broadway in New York City, New York 10032.
For its online presence, you may visit Neilaarshi Healthcare LLC’s website at and engage with its social media outlets through on Twitter and on Facebook.